Department of Mechanical and Materials Engineering, University of Denver, 2155 E. Wesley Ave, Room 439, Denver, CO, 80208, USA.
J Cardiovasc Transl Res. 2023 Jun;16(3):674-681. doi: 10.1007/s12265-022-10333-x. Epub 2022 Oct 19.
Subclinical leaflet thrombosis has been increasingly observed in patients undergoing transcatheter aortic valve replacement. Intra-annular transcatheter aortic valves (TAVs) have a larger neo-sinus volume than supra-annular devices and are potentially at a higher risk of hypoattenuated leaflet thickening (HALT). However, clinical data from randomized clinical trials have shown that approximately one-third of patients undergoing TAVR with intra- or supra-annular devices develop HALT in 1 year. The findings point to the potential role of leaflet design in developing HALT. The study aimed to systematically investigate leaflet kinematics of a supra-annular TAV, Medtronic CoreValve, and determine regions of blood stasis. Fluid-solid interaction simulations demonstrated the limited movement of CoreValve leaflets in the lower belly region that created regions of blood stasis on the surface of the leaflets. The findings provide insights into potential improvements in leaflet design in the next generation of TAVs to reduce the risk of HALT and leaflet immobility.
经导管主动脉瓣置换术后患者中越来越多地观察到亚临床瓣叶血栓形成。瓣环内经导管主动脉瓣(TAV)比瓣环上装置具有更大的新窦体积,并且潜在地处于低衰减瓣叶增厚(HALT)的风险更高。然而,来自随机临床试验的临床数据表明,接受 TAVR 的患者中有大约三分之一在 1 年内出现 HALT。这些发现表明瓣叶设计在发展 HALT 方面的潜在作用。该研究旨在系统地研究瓣环上 TAV、美敦力 CoreValve 的瓣叶运动,并确定血栓形成区域。流固相互作用模拟表明,CoreValve 瓣叶在下部腹部区域的运动有限,从而在瓣叶表面产生了血栓形成区域。这些发现为下一代 TAV 减少 HALT 和瓣叶不活动的风险提供了关于改进瓣叶设计的见解。